Hipgnosis Songs Fund Limited Strategic Review and Company Update (3938U)
November 23 2023 - 1:00AM
UK Regulatory
TIDMSONG
RNS Number : 3938U
Hipgnosis Songs Fund Limited
23 November 2023
LEI: 213800XJIPNDVKXMOC11
23 November 2023
Hipgnosis Songs Fund Limited
("Hipgnosis" or the "Company")
Strategic Review and Company Update
Further to the vote against the Company continuing its business
as a closed-ended investment company at the Company's Annual
General Meeting held on 26 October 2023, the Board announces an
update on the strategic review (the "Strategic Review").
Update on the Strategic Review
As part of the Strategic Review, the Board intends to appoint
independent advisers to conduct due diligence on the Company's
assets.
Completion of this due diligence will provide a strong knowledge
base from which the Board will commence a process of identifying
and bringing forward alternative proposals for the future of the
Company.
During this period, the Board has requested that Hipgnosis Song
Management Limited, the Company's Investment Adviser (" Investment
Adviser" ) , proposes alternative terms for their future investment
advisory arrangements to the Company.
Audit Tender
The Company is currently undertaking an audit tender process for
the 31 March 2024 audit. PwC have indicated they will not be
participating in the tender. The Company will confirm the new
auditor in due course.
Service of Claim
Further to the disclosure in the 2023 Annual Report, on page
100, Hipgnosis Music Limited (in liquidation since March 2018)
("Hipgnosis Music Limited") has served proceedings against Mr
Mercuriadis, the Investment Adviser and the Company in the English
High Court. In summary, Hipgnosis Music Limited alleges a diversion
of business opportunity from Hipgnosis Music Limited (of which Mr
Mercuriadis was previously a director) to the Company and the
Investment Adviser and also alleges that the Company unlawfully
assisted Mr Mercuriadis with, or received, this alleged diversion.
Mr Mercuriadis, the Investment Adviser and the Company deny such
claims and intend to vigorously defend them. The Company is not
insured as to the costs of dealing with this claim.
For further information please contact:
Hipgnosis Songs Fund
Robert Naylor / Sylvia Coleman
Via Singer Capital Markets +44 (0) 20 7496 3000
Hipgnosis Song Management
Merck Mercuriadis
Ben Katovsky +44 (0) 20 4542 1530
Giles Croot (Media) +44 (0) 20 4542 1511
Singer Capital Markets - Corporate Broker
James Moat / Alaina Wong / Angus Campbell
(Corporate Finance)
Alan Geeves / James Waterlow / Sam Greatrex
(Sales) +44 (0) 20 7496 3000
J.P. Morgan Cazenove - Corporate Broker
William Simmonds / Jérémie Birnbaum
(Corporate Finance) +44 (0) 20 3493 8000
RBC Capital Markets - Corporate Broker
Elliot Thomas / Max Avison (Corporate Finance) +44 (0) 20 7635 4000
Headland Consultancy - Financial PR
Susanna Voyle / Charlie Twigg +44 (0) 20 3805 4822
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
UPDLLLLLXFLLFBV
(END) Dow Jones Newswires
November 23, 2023 02:00 ET (07:00 GMT)
Hipgnosis Songs (LSE:SOND)
Historical Stock Chart
From Nov 2024 to Dec 2024
Hipgnosis Songs (LSE:SOND)
Historical Stock Chart
From Dec 2023 to Dec 2024